The $30 Billion Lie: Why Your Smartwatch Will Never Track Blood Sugar
The non-invasive glucose monitoring industry has raised billions chasing a physical impossibility. The real tragedy? That money could have made existing CGMs cheaper, smaller, and more reliable for the millions of diabetics who still pay out of pocket for sensors that break. This article explains why the technology is a dead end—and what we should demand instead.